drug-approval
News
FDA Approves New Targeted Drug for Leukemia
FDA Approves New Targeted Drug for Leukemia
Perelman School of Medicine at the University of Pennsylvania | Nov 29, 2018
Drug is the first to target common mutation associated with relapse and short survival in AML